Aktiviteetteja vuodessa
Aktiviteetit
- 1 - 50 osumaa 164 tuloksesta
Hakutulokset
-
Dexamethasone regulates gene expression in chondrocytes through MKP 1 and downregulates cholesterol hydroxylases CH25H and CYP7B1
Lehtola, T. (Contributor), Pemmari, A. (Contributor), Nummenmaa, E. (Contributor), Hämäläinen, M. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)
28 marrask. 2024 → 29 marrask. 2024Aktiviteetti: Konferenssiesitelmä
-
Transient receptor potential (TRP) channel expression in human osteoarthritic chondrocytes - TRPA1 and TRPM8 as potential drug targets
Halonen, L. (Contributor), Pemmari, A. (Contributor), Nummenmaa, E. (Contributor), Hämäläinen, M. (Contributor), Moilanen, T. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)
20 maalisk. 2024 → 22 maalisk. 2024Aktiviteetti: Konferenssiesitelmä
-
MKP-1 as a novel anti-inflammatory drug target: cAMP enhancing drugs salbutamol and rolipram promote alternative macrophage activation through MKP-1
Lehtola, T. (Contributor), Nummenmaa, E. (Contributor), Leppänen, T. (Contributor), Nieminen, R. (Contributor), Hämäläinen, M. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)
20 maalisk. 2024 → 22 maalisk. 2024Aktiviteetti: Konferenssiesitelmä
-
Meteorin-like protein is a novel factor and potential drug target in osteoarthritis
Vuolteenaho, K. (Contributor), Koskinen-Kolasa, A. (Contributor), Pemmari, A. (Contributor), Hämäläinen, M. (Contributor), Moilanen, T. (Contributor) & Moilanen, E. (Contributor)
20 maalisk. 2024 → 22 maalisk. 2024Aktiviteetti: Konferenssiesitelmä
-
MKP-1 as a novel anti-inflammatory drug target: cAMP enhancing drugs salbutamol and rolipram promote alternative macrophage activation through MKP-1
Lehtola, T. (Contributor), Nummenmaa, E. (Contributor), Leppänen, T. (Contributor), Nieminen, R. (Contributor), Hämäläinen, M. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)
30 marrask. 2023Aktiviteetti: Konferenssiesitelmä
-
Meteorin-like protein is a novel factor and potential drug target in osteoarthritis
Vuolteenaho, K. (Contributor), Koskinen-Kolasa, A. (Contributor), Pemmari, A. (Contributor), Hämäläinen, M. (Contributor), Moilanen, T. (Contributor) & Moilanen, E. (Contributor)
30 marrask. 2023Aktiviteetti: Konferenssiesitelmä
-
Myocardial MCP-1, IL-6 and E-Selectin expression is markedly increased in patients undergoing coronary artery bypass grafting surgery. A GWEA based pilot study.
Laurikka, A. (Speaker), Pemmari, A. (Contributor), Hämäläinen, M. (Contributor), Laurikka, J. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)
30 marrask. 2023Aktiviteetti: Konferenssiesitelmä
-
Transient receptor potential (TRP) channel expression in human osteoarthritic chondrocytes - TRPA1 and TRPM8 as potential drug targets
Halonen, L. (Contributor), Pemmari, A. (Contributor), Nummenmaa, E. (Contributor), Hämäläinen, M. (Contributor), Moilanen, T. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)
30 marrask. 2023Aktiviteetti: Konferenssiesitelmä
-
Human osteoarthritic chondrocytes express nineteen different TRP-genes – TRPA1 and TRPM8 as potential drug targets
Halonen, L. (Speaker), Pemmari, A. (Contributor), Nummenmaa, E. (Contributor), Hämäläinen, M. (Contributor), Moilanen, T. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)
2 heinäk. 2023 → 7 heinäk. 2023Aktiviteetti: Konferenssiesitelmä
-
cAMP enhancing drugs salbutamol and rolipram promote alternative macrophage activation through MKP-1 in murine macrophages
Lehtola, T. (Contributor), Nummenmaa, E. (Contributor), Leppänen, T. (Contributor), Nieminen, R. (Contributor), Hämäläinen, M. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)
2 heinäk. 2023 → 7 heinäk. 2023Aktiviteetti: Konferenssiesitelmä
-
Meteorin-like protein as a novel factor and potential drug target in osteoarthritis
Vuolteenaho, K. (Speaker), Koskinen-Kolasa, A. (Contributor), Pemmari, A. (Contributor), Hämäläinen, M. (Contributor), Moilanen, T. (Contributor) & Moilanen, E. (Contributor)
2 heinäk. 2023Aktiviteetti: Konferenssiesitelmä
-
Genome wide analysis of gene expression changes in atrial myocardium caused by coronary artery bypass grafting surgery with cardiopulmonary bypass: towards understanding mechanisms and therapeutic targets
Laurikka, A. (Speaker), Pemmari, A. (Contributor), Hämäläinen, M. (Contributor), Laurikka, J. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)
2 heinäk. 2023 → 7 heinäk. 2023Aktiviteetti: Konferenssiesitelmä
-
The glucocorticoid dexamethasone alleviates allergic inflammation through an MKP-1 dependent mechanism
Lehtola, T. (Contributor), Nummenmaa, E. (Contributor), Nieminen, R. (Contributor), Hämäläinen, M. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)
22 maalisk. 2023 → 24 maalisk. 2023Aktiviteetti: Konferenssiesitelmä
-
Genome wide analysis of gene expression changes in atrial myocardium caused by coronary artery bypass grafting surgery with cardiopulmonary bypass: towards understanding mechanisms and therapeutic targets
Laurikka, A. (Contributor), Pemmari, A. (Contributor), Hämäläinen, M. (Contributor), Laurikka, J. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)
22 maalisk. 2023 → 24 maalisk. 2023Aktiviteetti: Konferenssiesitelmä
-
The glucocorticoid dexamethasone alleviates acute allergic inflammatory reaction through an MKP-1 dependent mechanism
Lehtola, T. (Speaker), Nummenmaa, E. (Contributor), Nieminen, R. (Contributor), Hämäläinen, M. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)
24 marrask. 2022 → 25 marrask. 2022Aktiviteetti: Konferenssiesitelmä
-
Inflammatory glycoprotein YKL-40 is elevated after coronary artery bypass surgery and correlates with leukocyte chemotaxis and myocardial injury, a pilot study
Laurikka, A. (Speaker), Vuolteenaho, K. (Contributor), Toikkanen, V. (Contributor), Rinne, T. (Contributor), Leppänen, T. (Contributor), Hämäläinen, M. (Contributor), Tarkka, M. (Contributor), Laurikka, J. (Contributor) & Moilanen, E. (Contributor)
24 marrask. 2022 → 25 marrask. 2022Aktiviteetti: Konferenssiesitelmä
-
TRPA1 as a factor in osteoarthritis: TRPA1 (transient receptor potential ankyrin 1) mediates fibroblast growth factor-2 expression in chondrocytes
Nummenmaa, E. (Speaker), Hämäläinen, M. (Contributor), Pemmari, A. (Contributor), Moilanen, L. (Contributor), Nieminen, R. (Contributor), Moilanen, T. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)
25 marrask. 2021 → 26 marrask. 2021Aktiviteetti: Konferenssiesitelmä
-
Pinosylvin shifts macrophage polarization to support resolution of inflammation
Kivimäki, K. (Speaker), Leppänen, T. (Contributor), Hämäläinen, M. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)
25 marrask. 2021 → 26 marrask. 2021Aktiviteetti: Konferenssiesitelmä
-
Comprehensive effects of ibuprofen on gene expression in chondrocytes as determined by RNA-Seq
Hämäläinen, M. (Contributor), Leppänen, T. (Contributor), Moilanen, E. (Contributor) & Vuolteenaho, K. (Contributor)
29 marrask. 2019Aktiviteetti: Konferenssiesitelmä
-
Transient receptor potential ankyrin 1 (TRPA1) mediates FGF-2 expression in chondrocytes
Nummenmaa, E. (Contributor), Hämäläinen, M. (Contributor), Pemmari, A. (Contributor), Moilanen, E. (Contributor), Moilanen, L. (Contributor), Nieminen, R. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, T. (Contributor)
29 marrask. 2019Aktiviteetti: Konferenssiesitelmä
-
Comprehensive effects of ibuprofen on gene expression in chondrocytes as determined by RNA-Seq
Pemmari, A. (Contributor), Tuure, L. (Contributor), Hämäläinen, M. (Contributor), Leppänen, T. (Contributor), Vuolteenaho, K. (Contributor), Moilanen, T. (Contributor) & Moilanen, E. (Contributor)
2 toukok. 2019Aktiviteetti: Konferenssiesitelmä
-
Transient receptor potential ankyrin 1 (TRPA1) as a factor and drug target in osteoarthritis: TRPA1 mediates fibroblast growth factor 2 expression in chondrocytes
Hämäläinen, M. (Contributor), Moilanen, E. (Contributor), Nieminen, R. (Contributor), Pemmari, A. (Contributor) & Vuolteenaho, K. (Contributor)
2 toukok. 2019Aktiviteetti: Konferenssiesitelmä
-
Comprehensive effects of ibuprofen on gene expression in chondrocytes as determined by RNA-Seq
Pemmari, A. (Contributor), Hämäläinen, M. (Contributor), Leppänen, T. (Contributor), Moilanen, E. (Contributor) & Vuolteenaho, K. (Contributor)
20 maalisk. 2019Aktiviteetti: Konferenssiesitelmä
-
Transient receptor potential ankyrin 1 (TRPA1) mediates fibroblast growth factor-2 (FGF-2) expression in chondrocytes
Hämäläinen, M. (Contributor), Moilanen, E. (Contributor), Nieminen, R. (Contributor), Pemmari, A. (Contributor) & Vuolteenaho, K. (Contributor)
20 maalisk. 2019Aktiviteetti: Konferenssiesitelmä
-
Comprehensive effects of ibuprofen on gene expression in chondrocytes as determined by RNA-Seq
Pemmari, A. (Speaker), Tuure, L. (Speaker), Hämäläinen, M. (Speaker), Leppänen, T. (Speaker), Vuolteenaho, K. (Speaker), Moilanen, T. (Speaker) & Moilanen, E. (Speaker)
24 tammik. 2019Aktiviteetti: Konferenssiesitelmä
-
Transient receptor potential ankyrin 1 (TRPA1) mediates FGF-2 expression in chondrocytes
Nummenmaa, E. (Speaker), Hämäläinen, M. (Speaker), Moilanen, E. (Speaker), Nieminen, R. (Speaker) & Vuolteenaho, K. (Speaker)
24 tammik. 2019Aktiviteetti: Konferenssiesitelmä
-
Adipokines and disease activity in patients with newly diagnosed inflammatory joint diseases
Kononoff, A. (Speaker), Vuolteenaho, K. (Speaker), Hämäläinen, M. (Speaker), Kautiainen, H. (Speaker), Elfving, P. (Speaker), Savolainen, E. (Speaker), Arstila, L. (Speaker), Niinisalo, H. (Speaker), Rutanen, J. (Speaker), Marjoniemi, O. (Speaker), Moilanen, E. (Speaker) & Kaipiainen-Seppänen, O. (Speaker)
24 tammik. 2019Aktiviteetti: Konferenssiesitelmä
-
TRPA1 as a novel factor in osteoarthritis: TRPA1 ion channel mediates MIA-induced acute inflammation and contributes to the development of cartilage degradation and joint pain in the MIA-model of osteoarthritis
Hämäläinen, M. (Contributor), Lehtimäki, L. (Contributor), Moilanen, E. (Contributor), Nieminen, R. (Contributor), Nummenmaa, E. (Contributor) & Vuolteenaho, K. (Contributor)
23 marrask. 2018Aktiviteetti: Konferenssiesitelmä
-
Novel adipokine associated with osteoarthritis: retinol binding protein 4 is produced by cartilage and correlates with matrix metalloproteinases in osteoarthritis patients
Leppänen, T. (Contributor), Hämäläinen, M. (Contributor), Moilanen, E. (Contributor) & Vuolteenaho, K. (Contributor)
23 marrask. 2018Aktiviteetti: Konferenssiesitelmä
-
TRPA1 as a factor in osteoarthritis: TRPA1 (Transient receptor potential ankyrin 1) mediates interleukin-6 expression in chondrocytes
Nummenmaa, E. (Contributor), Hämäläinen, M. (Contributor), Moilanen, E. (Contributor), Nieminen, R. (Contributor) & Vuolteenaho, K. (Contributor)
23 marrask. 2018Aktiviteetti: Konferenssiesitelmä
-
IL-6 in osteoarthritis: effects of pinosylvin and monomethyl pinosylvin
Laavola, M. (Contributor), Leppänen, T. (Contributor), Hämäläinen, M. (Contributor), Vuolteenaho, K. (Contributor), Moilanen, T. (Contributor), Nieminen, R. (Contributor) & Moilanen, E. (Contributor)
23 marrask. 2018Aktiviteetti: Konferenssiesitelmä
-
IL-6 in osteoarthritis: effects of pinosylvin and monomethyl pinosylvin
Laavola, M. (Contributor), Leppänen, T. (Contributor), Hämäläinen, M. (Contributor), Vuolteenaho, K. (Contributor), Moilanen, T. (Contributor), Nieminen, R. (Contributor) & Moilanen, E. (Contributor)
5 syysk. 2018Aktiviteetti: Konferenssiesitelmä
-
TRPA1 as a novel factor in osteoarthritis: TRPA1 ion channel mediates MIA-induced acute inflammation and contributes to the development of cartilage degradation and joint pain in the MIA-model of osteoarthritis
Hämäläinen, M. (Speaker), Männistö, L. (Speaker), Moilanen, E. (Speaker), Nieminen, R. (Speaker), Nummenmaa, E. (Speaker) & Vuolteenaho, K. (Speaker)
5 syysk. 2018Aktiviteetti: Konferenssiesitelmä
-
TRPA1 as a factor in osteoarthritis: TRPA1 (Transient receptor potential ankyrin 1) mediates interleukin-6 expression in chondrocytes
Nummenmaa, E. (Contributor), Hämäläinen, M. (Contributor), Pemmari, A. (Contributor), Moilanen, L. (Contributor), Nieminen, R. (Contributor), Moilanen, T. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)
5 syysk. 2018Aktiviteetti: Konferenssiesitelmä
-
Widespread regulation of gene expression by glucocorticoids in chondrocytes from OA patients as determined by next generation sequencing-based genome wide expression analysis
Pemmari, A. (Speaker), Syvänen, T. (Speaker), Hämäläinen, M. (Speaker), Moilanen, T. (Speaker), Vuolteenaho, K. (Speaker) & Moilanen, E. (Speaker)
5 syysk. 2018Aktiviteetti: Konferenssiesitelmä
-
Novel adipokine associated with osteoarthritis: retinol binding protein 4 is produced by cartilage and correlates with matrix metalloproteinases in osteoarthritis patients
Scotece, M. (Contributor), Koskinen-Kolasa, A. (Contributor), Pemmari, A. (Contributor), Leppänen, T. (Contributor), Hämäläinen, M. (Contributor), Moilanen, T. (Contributor), Moilanen, E. (Contributor) & Vuolteenaho, K. (Contributor)
5 syysk. 2018Aktiviteetti: Konferenssiesitelmä
-
Novel adipokine associated with osteoarthritis: retinol binding protein 4 is produced by cartilage and correlates with matrix metalloproteinases in osteoarthritis patients
Moilanen, E. (Contributor) & Vuolteenaho, K. (Contributor)
26 huhtik. 2018Aktiviteetti: Konferenssiesitelmä
-
TRPA1 as a factor and drug target in osteoarthritis: TRPA1 (transient receptor potential ankyrin 1) mediates interleukin-6 expression in chondrocytes
Nummenmaa, E. (Contributor), Hämäläinen, M. (Contributor), Moilanen, E. (Contributor), Nieminen, R. (Contributor), Pemmari, A. (Contributor) & Vuolteenaho, K. (Contributor)
26 huhtik. 2018Aktiviteetti: Konferenssiesitelmä
-
Widespread regulation of gene expression by glucocorticoids in chondrocytes from OA patients as determined by next generation sequencing-based genome wide expression analysis
Pemmari, A. (Speaker), Hämäläinen, M. (Speaker), Leppänen, T. (Speaker), Moilanen, E. (Speaker) & Vuolteenaho, K. (Speaker)
24 huhtik. 2018Aktiviteetti: Konferenssiesitelmä
-
Transient receptor potential ankyrin 1 (TRPA1) mediates interleukin-6 expression in chondrocytes
Nummenmaa, E. (Contributor), Hämäläinen, M. (Contributor), Moilanen, E. (Contributor), Nieminen, R. (Contributor), Pemmari, A. (Contributor) & Vuolteenaho, K. (Contributor)
24 huhtik. 2018Aktiviteetti: Konferenssiesitelmä
-
Novel adipokine associated with osteoarthritis (OA): Retinol binding protein 4 is produced by cartilage and correlates with matrix metalloproteinases in OA patients
Scotece, M. (Contributor), Koskinen-Kolasa, A. (Contributor), Moilanen, T. (Contributor), Moilanen, E. (Contributor) & Vuolteenaho, K. (Contributor)
24 huhtik. 2018Aktiviteetti: Konferenssiesitelmä
-
Adipokine retinol binding protein 4 is expressed in chondrocytes and correlates with matrix metalloproteinases in osteoarthritis patients
Scotece, M. (Contributor), Koskinen-Kolasa, A. (Contributor), Moilanen, T. (Contributor), Moilanen, E. (Contributor) & Vuolteenaho, K. (Contributor)
21 maalisk. 2018Aktiviteetti: Konferenssiesitelmä
-
Transient receptor potential ankyrin 1 (TRPA1) mediates IL-6 expression in chondrocytes
Nummenmaa, E. (Contributor), Hämäläinen, M. (Contributor), Pemmari, A. (Contributor), Moilanen, L. (Contributor), Nieminen, R. (Contributor), Moilanen, T. (Contributor), Vuolteenaho, K. (Contributor) & Moilanen, E. (Contributor)
21 maalisk. 2018Aktiviteetti: Konferenssiesitelmä
-
Adipokine retinol binding protein 4 is expressed in chondrocytes and correlates with matrix metalloproteinases in osteoarthritis patients
Moilanen, E. (Speaker) & Vuolteenaho, K. (Speaker)
25 tammik. 2018Aktiviteetti: Konferenssiesitelmä
-
Transient receptor potential ankyrin 1 (TRPA1) mediates IL-6 expression in chondrocytes
Nummenmaa, E. (Speaker), Hämäläinen, M. (Speaker), Pemmari, A. (Speaker), Moilanen, L. (Speaker), Nieminen, R. (Speaker), Moilanen, T. (Speaker), Vuolteenaho, K. (Speaker) & Moilanen, E. (Speaker)
25 tammik. 2018Aktiviteetti: Konferenssiesitelmä
-
IL-6 in osteoarthritis: effects of pinosylvin and monomethyl pinosylvin
Laavola, M. (Speaker), Leppänen, T. (Speaker), Hämäläinen, M. (Speaker), Vuolteenaho, K. (Speaker), Moilanen, T. (Speaker), Nieminen, R. (Speaker) & Moilanen, E. (Speaker)
25 tammik. 2018Aktiviteetti: Konferenssiesitelmä
-
High synovial fluid interleukin-6 levels are associated with increased matrix metalloproteinase levels and severe radiographic changes in osteoarthritis patients
Vuolteenaho, K. (Contributor), Koskinen-Kolasa, A. (Contributor), Laavola, M. (Contributor), Nieminen, R. (Contributor), Moilanen, T. (Contributor) & Moilanen, E. (Contributor)
26 lokak. 2017Aktiviteetti: Konferenssiesitelmä
-
Widespread regulation of gene expression by glucocorticoids in chondrocytes from OA patients as determined by RNA-Seq-based genome wide expression analysis
Pemmari, A. (Contributor), Hämäläinen, M. (Contributor), Leppänen, T. (Contributor), Moilanen, E. (Contributor) & Vuolteenaho, K. (Contributor)
26 lokak. 2017Aktiviteetti: Konferenssiesitelmä
-
Transient receptor potential ankyrin 1 (TRPA1) expression is downregulated by dexamethasone and aurothiomalate in human chondrocytes
Nummenmaa, E. (Contributor), Hämäläinen, M. (Contributor), Moilanen, E. (Contributor), Nieminen, R. (Contributor) & Vuolteenaho, K. (Contributor)
26 lokak. 2017Aktiviteetti: Konferenssiesitelmä
-
TRPA1 elicits inflammatory effects in chondrocytes and its expression is downregulated by anti-inflammatory drugs dexamethasone and aurothiomalate
Nummenmaa, E. (Speaker), Hämäläinen, M. (Speaker), Moilanen, L. (Speaker), Paukkeri, E.-L. (Speaker), Nieminen, R. (Speaker), Moilanen, T. (Speaker), Vuolteenaho, K. (Speaker) & Moilanen, E. (Speaker)
10 heinäk. 2017Aktiviteetti: Konferenssiesitelmä